Browse
Submit Data
Databases
API
Help

Dataset Information

0 Views

0 Connections

0 Citations

0 Reanalyses

0 Downloads

Omics score: 0

Transcriptome analysis of RFWD2 overexpression (OE) and control (WT) in Multiple myeloma

ABSTRACT: Transcriptome analysis of RFWD2 overexpression (OE) and control (WT) in Multiple myeloma

PROVIDER: PRJNA627911 | ENA |

REPOSITORIES: ENA

ACCESS DATA

Json Xml

Dataset's files

Source:

			Action	DRS
	SRR11605278_1.fastq.gz	Fastqsanger.gz
	SRR11605278_2.fastq.gz	Fastqsanger.gz
	SRR11605279_1.fastq.gz	Fastqsanger.gz
	SRR11605279_2.fastq.gz	Fastqsanger.gz
	SRR11605280_1.fastq.gz	Fastqsanger.gz

Items per page:

1 - 5 of 8

Similar Datasets

Transcriptome analysis of G6PD overexpression(OE) and wildtype(WT) cells in Multiple Myeloma

Project description:Transcriptome analysis of G6PD overexpression(OE) and wildtype(WT) cells in Multiple Myeloma

| PRJNA722941 | ENA

Transcriptome analysis of G6PD overexpression(OE) and wildtype(WT) cells in Multiple Myeloma

Project description:RNA-seq experiments was conducted to analyze changes in related signaling pathways and gene expression in multiple myeloma cells when G6PD was overexpression.

2021-04-20 | GSE172318 | GEO

Transcriptome analysis of RFWD2 overexpression (OE) and control (WT) in Multiple myeloma

Project description:Transcriptome sequencing was used to analyze changes in related signaling pathways and gene expression in Multpile myeloma cells when RFWD2 overexpressed.

2020-04-25 | GSE149292 | GEO

Genome-wide maps of chromatin state in AIMP1 overexpression (OE) and wildtype (WT) cells in multiple myeloma

Project description:Genome-wide maps of chromatin state in AIMP1 overexpression (OE) and wildtype (WT) cells in multiple myeloma

| PRJNA682831 | ENA

Multiple myeloma

Project description:Multiple myeloma

| PRJNA515992 | ENA

Genome-wide maps of transcription in PNPO overexpression(OE) and wildtype(WT) cells in Multiple Myeloma

Project description:We found different genes change between WT and OE cells.

2023-06-15 | GSE181017 | GEO

Transcriptome analysis of AIMP1 overexpression (OE) or knockdown (KD) or cells treatedwith AIMP1 protein compared with wildtype (WT) cells in multiple myeloma

Project description:Transcriptome sequencing was used to analyze changes in related signaling pathways and gene expression in multiple myeloma cells when AIMP1 overexpressed, knockdowned or treated with AIMP1 protein.

2021-07-31 | GSE162700 | GEO

Multiple Myeloma cells

Project description:Multiple Myeloma cells

| PRJNA800411 | ENA

Transcriptome analysis of AIMP1 overexpression (OE) or knockdown (KD) or cells treatedwith AIMP1 protein compared with wildtype (WT) cells in multiple myeloma

Project description:Transcriptome analysis of AIMP1 overexpression (OE) or knockdown (KD) or cells treatedwith AIMP1 protein compared with wildtype (WT) cells in multiple myeloma

| PRJNA682630 | ENA

TRIM21 enhances bortezomib sensitivity in multiple myeloma by halting pro-survival autophagy

Project description:Bortezomib (bort) is an effective therapeutic agent for multiple myeloma (MM) patients; however, the majority of patients develop drug resistance. Autophagy, a highly conserved process that recycles cytosol or entire organelles via lysosomal activity, is essential for the survival, homeostasis and drug resistance in MM. Growing evidence has highlighted that E3 ligase tripartite motif-containing protein 21 (TRIM21) not only interacts with multiple autophagy regulators but also participates in drug resistance in various cancers. However, to date, the direct substrates and additional roles of TRIM21 in MM remain unexplored. In this study, we demonstrated that low TRIM21 expression is a factor for relapse in MM. TRIM21 knockdown (KD) made MM cells more resistant to bort, while TRIM21 overexpression (OE) resulted in increased MM sensitivity to bort. Proteomic and phospho-proteomic studies of TRIM21 KD MM cells showed that bort resistance was associated with increased oxidative stress and elevated pro-survival autophagy. Our results provided that TRIM21 KD MM cell lines induced pro-survival autophagy after bort treatment, and suppressing autophagy by 3-methyladenine treatment or by the short hairpin RNA of ATG5 restored bort sensitivity. Indeed, autophagy-related gene 5 (ATG5) expression was increased and decreased by TRIM21 KD and OE, respectively. TRIM21 affected autophagy by ubiquitinating ATG5 through K48 for proteasomal degradation. Importantly, we confirmed that TRIM21 could potentiate the anti-myeloma effect of bort through in vitro and in vivo experiments. Overall, our findings define the key role of TRIM21 in MM bort resistance and provide a foundation for a novel targeted therapeutic approaches.

2023-10-24 | PXD042004 | Pride

OmicsDI is part of the ELIXIR infrastructure

OmicsDI is an Elixir interoperability service. Learn more ›

Tweets

OmicsDI Databases

PRIDE
PeptideAtlas
MassIVE
JPOST Repository
Physiome Model Repository

EGA
EVA
ENA
LINCS
PAXDB
Cell Collective

MetaboLights
Metabolomics Workbench
MetabolomeExpress
GNPS
BioModels
FAIRDOMHub

ArrayExpress
dbGaP
ExpressionAtlas
GEO
NODE

Information

Databases
Help
API
Contact us
Code on GitHub
Terms of use
Submit Data